Atlas Trials

A Study of AC-101 Tablets in Patients With Ulcerative Colitis

Clinical trial NCT07755241 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07755241
Sponsor
Accro Bioscience (Suzhou) Limited
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis (UC)
Start date
2026-08-28
Primary completion
2027-11-30
Enrollment
153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.